Spot On CML
A Breakthrough Diagnostic Test Offered to Patients With the Greatest Need
Since 2017, The Max Foundation and Dr. Jerry Radich of the Fred Hutchinson Cancer Research Center have partnered to tackle the problem of access to accurate testing for chronic myeloid leukemia (CML) in low- and middle-income countries (LMICs) through a program called Spot On CML.
Dr. Radich has developed a low-cost, paper-based diagnostic testing method for CML. Previously, vials of blood were sent to labs in Europe and the U.S. for testing, which was both costly and unreliable – vials were often damaged in transit. With this new method, a physician spots a patient’s blood onto a test card and sends the card to Dr. Radich’s lab at the Fred Hutch for processing. He and his team are able to perform accurate testing on the samples even after weeks of transport. Once patients are diagnosed, Max connects them with available treatments free of charge. The free treatment is made possible thanks to Max’s partnerships with pharmaceutical companies to provide cancer drugs to patients in need in specified LMICs.
Nearly two years in, Spot On CML has provided access to testing and a pathway to treatment for more than 500 patients in 19 countries.